These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 23538226)

  • 21. Proteasome inhibition profoundly affects activated human B cells.
    Mulder A; Heidt S; Vergunst M; Roelen DL; Claas FH
    Transplantation; 2013 Jun; 95(11):1331-7. PubMed ID: 23624544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An autophagy inhibitor enhances the inhibition of cell proliferation induced by a proteasome inhibitor in MCF-7 cells.
    Yao F; Wang G; Wei W; Tu Y; Tong H; Sun S
    Mol Med Rep; 2012 Jan; 5(1):84-8. PubMed ID: 21931937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of a new series of non-covalent proteasome inhibitors with exquisite potency and selectivity for the 20S beta5-subunit.
    Blackburn C; Gigstad KM; Hales P; Garcia K; Jones M; Bruzzese FJ; Barrett C; Liu JX; Soucy TA; Sappal DS; Bump N; Olhava EJ; Fleming P; Dick LR; Tsu C; Sintchak MD; Blank JL
    Biochem J; 2010 Sep; 430(3):461-76. PubMed ID: 20632995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myeloma.
    Kuhn DJ; Chen Q; Voorhees PM; Strader JS; Shenk KD; Sun CM; Demo SD; Bennett MK; van Leeuwen FW; Chanan-Khan AA; Orlowski RZ
    Blood; 2007 Nov; 110(9):3281-90. PubMed ID: 17591945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of autophagy enhances apoptosis induced by proteasome inhibitor bortezomib in human glioblastoma U87 and U251 cells.
    Zhang X; Li W; Wang C; Leng X; Lian S; Feng J; Li J; Wang H
    Mol Cell Biochem; 2014 Jan; 385(1-2):265-75. PubMed ID: 24104452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simultaneous inhibition of hsp 90 and the proteasome promotes protein ubiquitination, causes endoplasmic reticulum-derived cytosolic vacuolization, and enhances antitumor activity.
    Mimnaugh EG; Xu W; Vos M; Yuan X; Isaacs JS; Bisht KS; Gius D; Neckers L
    Mol Cancer Ther; 2004 May; 3(5):551-66. PubMed ID: 15141013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of the human proteasome by imidazoline scaffolds.
    Azevedo LM; Lansdell TA; Ludwig JR; Mosey RA; Woloch DK; Cogan DP; Patten GP; Kuszpit MR; Fisk JS; Tepe JJ
    J Med Chem; 2013 Jul; 56(14):5974-8. PubMed ID: 23789888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cooperative cytotoxicity of proteasome inhibitors and tumor necrosis factor-related apoptosis-inducing ligand in chemoresistant Bcl-2-overexpressing cells.
    Nencioni A; Wille L; Dal Bello G; Boy D; Cirmena G; Wesselborg S; Belka C; Brossart P; Patrone F; Ballestrero A
    Clin Cancer Res; 2005 Jun; 11(11):4259-65. PubMed ID: 15930365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential cellular and molecular effects of bortezomib, a proteasome inhibitor, in human breast cancer cells.
    Codony-Servat J; Tapia MA; Bosch M; Oliva C; Domingo-Domenech J; Mellado B; Rolfe M; Ross JS; Gascon P; Rovira A; Albanell J
    Mol Cancer Ther; 2006 Mar; 5(3):665-75. PubMed ID: 16546981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The generation of MHC class I-associated peptides is only partially inhibited by proteasome inhibitors: involvement of nonproteasomal cytosolic proteases in antigen processing?
    Vinitsky A; Antón LC; Snyder HL; Orlowski M; Bennink JR; Yewdell JW
    J Immunol; 1997 Jul; 159(2):554-64. PubMed ID: 9218569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteasome inhibition can impair caspase-8 activation upon submaximal stimulation of apoptotic tumor necrosis factor-related apoptosis inducing ligand (TRAIL) signaling.
    Laussmann MA; Passante E; Hellwig CT; Tomiczek B; Flanagan L; Prehn JH; Huber HJ; Rehm M
    J Biol Chem; 2012 Apr; 287(18):14402-11. PubMed ID: 22408249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of proteasome inhibitor bortezomib on proliferation, apoptosis and SHIP gene expression in K562 cells].
    Jia ZQ; Wei YT; Li AM; Cheng ZY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):916-9. PubMed ID: 23998585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Minimal effect of bortezomib in reducing anti-pig antibodies in human leukocyte antigen-sensitized patients: a pilot study.
    Hara H; Bentall A; Long C; Fang J; Andreyev O; Lunz J; Ezzelarab M; Abu-Elmagd KM; Shapiro R; Ayares D; Stegall M; Cooper DK
    Xenotransplantation; 2013; 20(6):429-37. PubMed ID: 23998233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteasome inhibitors.
    Cvek B
    Prog Mol Biol Transl Sci; 2012; 109():161-226. PubMed ID: 22727422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of Tumor Antigens in the HLA Peptidome of Patient-derived Xenograft Tumors in Mouse.
    Rijensky NM; Blondheim Shraga NR; Barnea E; Peled N; Rosenbaum E; Popovtzer A; Stemmer SM; Livoff A; Shlapobersky M; Moskovits N; Perry D; Rubin E; Haviv I; Admon A
    Mol Cell Proteomics; 2020 Aug; 19(8):1360-1374. PubMed ID: 32451349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of the ubiquitin proteasome pathway in a mouse model of inflammatory myopathy: a potential therapeutic target.
    Rayavarapu S; Coley W; Van der Meulen JH; Cakir E; Tappeta K; Kinder TB; Dillingham BC; Brown KJ; Hathout Y; Nagaraju K
    Arthritis Rheum; 2013 Dec; 65(12):3248-58. PubMed ID: 24022788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteasome inhibition suppresses essential immune functions of human CD4+ T cells.
    Berges C; Haberstock H; Fuchs D; Miltz M; Sadeghi M; Opelz G; Daniel V; Naujokat C
    Immunology; 2008 Jun; 124(2):234-46. PubMed ID: 18217957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HDAC inhibitor L-carnitine and proteasome inhibitor bortezomib synergistically exert anti-tumor activity in vitro and in vivo.
    Huang H; Liu N; Yang C; Liao S; Guo H; Zhao K; Li X; Liu S; Guan L; Liu C; Xu L; Zhang C; Song W; Li B; Tang P; Dou QP; Liu J
    PLoS One; 2012; 7(12):e52576. PubMed ID: 23285100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteasome inhibition blocks NF-κB and ERK1/2 pathways, restores antigen expression, and sensitizes resistant human melanoma to TCR-engineered CTLs.
    Jazirehi AR; Economou JS
    Mol Cancer Ther; 2012 Jun; 11(6):1332-41. PubMed ID: 22532603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antitumor effects of proteasome inhibition in anaplastic thyroid carcinoma.
    Altmann A; Markert A; Askoxylakis V; Schöning T; Jesenofsky R; Eisenhut M; Haberkorn U
    J Nucl Med; 2012 Nov; 53(11):1764-71. PubMed ID: 23055533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.